Sort
78,016 grants matching “breast cancer”
Insulin and IGF In female colon, breast, uterine cancer
$572,830Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · CA
Project 2
$572,796Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2014 · CA
Comprehensive Analysis of Estrogen Receptor Genomic Action
$572,709Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2007 · DK
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
$572,699Catherine C Park · University Of California, San Francisco · R01 · FY2017 · CA
High Deductible Insurance: Impact on Breast Cancer Care and Outcomes
$572,681James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2015 · CA
Background-free molecular imaging using modulated photoacoustics and targeted contrast agent
$572,589Robert M Dickson · Georgia Institute Of Technology · R01 · FY2023 · EB
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$572,575Michael Schwartz · Mount Sinai Medical Center (Miami Beach) · U10 · FY2011 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$572,572Michael Schwartz · Mount Sinai Medical Center (Miami Beach) · U10 · FY2012 · CA
Therapy for Metastatic breast cancer based on micro RNA silencing
$572,534Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2018 · CA
PROCESSES AND OUTCOMES OF BREAST CANCER CARE
$572,530Rand Corporation · R01 · FY2001 · CA
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
$572,529Jin Wang · Baylor College Of Medicine · R01 · FY2021 · CA
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$572,521Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER
$572,505Benjamin M Craig · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Separation and Analytical Technologies for Proteomics
$572,496Barry L. Karger · Northeastern University · R01 · FY2010 · GM
Pillar: Multi-Modal Imaging AI Models for Breast Cancer Risk
$572,490Adam Yala · University Of California, San Francisco · R37 · FY2025 · CA
Mechanisms of Genetic Instability and Tumor Suppression
$572,477Salk Institute For Biological Studies · R01 · FY2002 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast
$572,435Randa A El-Zein · Methodist Hospital Research Institute · U01 · FY2018 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast
$572,435Randa A El-Zein · Methodist Hospital Research Institute · U01 · FY2017 · CA
Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy
$572,426Scott D Larsen · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Proteomics Biomarkers Development Laboratory
$572,408Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2007 · CA
Development of a Low Cost High Performance Animal PET
$572,346Wai-Hoi Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · EB
Epidemiologic Field Studies
$572,342Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
$572,330Jeanine M. Genkinger · Columbia University Health Sciences · R01 · FY2017 · CA
Development of chemical probe targeting NSD3 SET domain in breast cancer
$572,327Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Development of chemical probe targeting NSD3 SET domain in breast cancer
$572,327Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2025 · CA